John Dornhoffer
Concepts (386)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tympanoplasty | 23 | 2020 | 58 | 7.350 |
Why?
| Cochlear Implantation | 10 | 2022 | 72 | 4.860 |
Why?
| Mastoid | 20 | 2019 | 51 | 4.820 |
Why?
| Cochlear Implants | 9 | 2022 | 58 | 4.350 |
Why?
| Hearing Loss, Conductive | 16 | 2019 | 54 | 3.970 |
Why?
| Hearing Aids | 9 | 2017 | 67 | 3.390 |
Why?
| Cholesteatoma, Middle Ear | 16 | 2017 | 32 | 2.910 |
Why?
| Ossicular Replacement | 12 | 2018 | 27 | 2.820 |
Why?
| Hearing Loss, Sensorineural | 11 | 2022 | 75 | 2.810 |
Why?
| Tinnitus | 13 | 2017 | 60 | 2.550 |
Why?
| Stapes Surgery | 8 | 2020 | 23 | 2.500 |
Why?
| Cartilage | 12 | 2020 | 48 | 2.490 |
Why?
| Otologic Surgical Procedures | 12 | 2023 | 38 | 2.390 |
Why?
| Treatment Outcome | 51 | 2022 | 5141 | 2.320 |
Why?
| Hearing Loss | 6 | 2023 | 90 | 2.030 |
Why?
| Transcranial Magnetic Stimulation | 10 | 2017 | 70 | 1.960 |
Why?
| Tympanic Membrane Perforation | 6 | 2020 | 19 | 1.920 |
Why?
| Retrospective Studies | 53 | 2023 | 6108 | 1.890 |
Why?
| Ear Ossicles | 8 | 2017 | 16 | 1.870 |
Why?
| Tympanic Membrane | 12 | 2020 | 38 | 1.810 |
Why?
| Ossicular Prosthesis | 9 | 2020 | 19 | 1.770 |
Why?
| Hearing | 10 | 2017 | 59 | 1.770 |
Why?
| Hearing Loss, Unilateral | 4 | 2016 | 12 | 1.750 |
Why?
| Child | 47 | 2024 | 6847 | 1.650 |
Why?
| Otorhinolaryngologic Surgical Procedures | 4 | 2019 | 34 | 1.630 |
Why?
| Adolescent | 43 | 2024 | 6356 | 1.610 |
Why?
| Postoperative Complications | 16 | 2024 | 984 | 1.560 |
Why?
| Ear Diseases | 5 | 2023 | 26 | 1.520 |
Why?
| Osseointegration | 3 | 2017 | 32 | 1.480 |
Why?
| Humans | 120 | 2024 | 49974 | 1.450 |
Why?
| Adult | 64 | 2024 | 13236 | 1.420 |
Why?
| Bone Conduction | 11 | 2017 | 26 | 1.410 |
Why?
| Male | 78 | 2024 | 25241 | 1.410 |
Why?
| Otolaryngology | 4 | 2019 | 55 | 1.390 |
Why?
| Female | 78 | 2024 | 26472 | 1.360 |
Why?
| Middle Aged | 53 | 2024 | 12069 | 1.270 |
Why?
| Meniere Disease | 9 | 2020 | 18 | 1.270 |
Why?
| Ear Canal | 6 | 2013 | 13 | 1.260 |
Why?
| Child, Preschool | 26 | 2024 | 3871 | 1.250 |
Why?
| Aged | 43 | 2024 | 9310 | 1.200 |
Why?
| Patient Satisfaction | 3 | 2018 | 273 | 1.110 |
Why?
| Semicircular Canals | 3 | 2019 | 13 | 1.030 |
Why?
| Young Adult | 19 | 2023 | 3958 | 1.020 |
Why?
| Audiometry, Pure-Tone | 18 | 2017 | 48 | 0.940 |
Why?
| Reoperation | 13 | 2020 | 454 | 0.920 |
Why?
| Smoking | 3 | 2016 | 511 | 0.920 |
Why?
| Otitis Media, Suppurative | 2 | 2016 | 9 | 0.890 |
Why?
| Audiometry | 7 | 2020 | 34 | 0.850 |
Why?
| Otosclerosis | 2 | 2020 | 9 | 0.850 |
Why?
| Costs and Cost Analysis | 3 | 2018 | 95 | 0.840 |
Why?
| Malleus | 4 | 2019 | 11 | 0.830 |
Why?
| Cleft Palate | 3 | 2021 | 77 | 0.810 |
Why?
| Surgical Flaps | 4 | 2016 | 119 | 0.800 |
Why?
| Craniocerebral Trauma | 1 | 2022 | 67 | 0.790 |
Why?
| Temporal Bone | 6 | 2013 | 35 | 0.770 |
Why?
| Biocompatible Materials | 6 | 2005 | 69 | 0.760 |
Why?
| Aged, 80 and over | 13 | 2019 | 3129 | 0.760 |
Why?
| Auditory Threshold | 8 | 2010 | 49 | 0.710 |
Why?
| Follow-Up Studies | 19 | 2014 | 2182 | 0.710 |
Why?
| Neuroma, Acoustic | 5 | 2008 | 20 | 0.700 |
Why?
| Receptors, Atrial Natriuretic Factor | 3 | 2005 | 8 | 0.680 |
Why?
| Ear Cartilage | 2 | 2016 | 5 | 0.660 |
Why?
| Quality of Life | 2 | 2019 | 836 | 0.650 |
Why?
| Neuronal Plasticity | 1 | 2019 | 58 | 0.650 |
Why?
| Patient Preference | 1 | 2019 | 36 | 0.650 |
Why?
| Intraoperative Period | 1 | 2018 | 45 | 0.630 |
Why?
| Eustachian Tube | 3 | 2023 | 14 | 0.630 |
Why?
| Neurotology | 1 | 2018 | 7 | 0.620 |
Why?
| Space Motion Sickness | 3 | 2012 | 5 | 0.600 |
Why?
| Ear, Inner | 5 | 2013 | 17 | 0.570 |
Why?
| Valsalva Maneuver | 1 | 2016 | 7 | 0.560 |
Why?
| Child Behavior Disorders | 1 | 2017 | 79 | 0.560 |
Why?
| Child Behavior | 1 | 2017 | 106 | 0.550 |
Why?
| Otitis Media with Effusion | 2 | 2010 | 15 | 0.550 |
Why?
| Treatment Failure | 1 | 2016 | 114 | 0.530 |
Why?
| Positron-Emission Tomography | 4 | 2011 | 295 | 0.520 |
Why?
| Temporal Lobe | 4 | 2017 | 70 | 0.510 |
Why?
| Stapes | 5 | 2020 | 12 | 0.500 |
Why?
| Equipment Failure | 2 | 2013 | 62 | 0.500 |
Why?
| Vertigo | 6 | 2020 | 17 | 0.490 |
Why?
| Labyrinth Diseases | 4 | 2000 | 7 | 0.490 |
Why?
| Durapatite | 3 | 2003 | 24 | 0.480 |
Why?
| Atrial Natriuretic Factor | 2 | 2005 | 21 | 0.470 |
Why?
| Ear, Middle | 4 | 2018 | 19 | 0.470 |
Why?
| Arousal | 5 | 2007 | 98 | 0.460 |
Why?
| Regional Blood Flow | 2 | 2011 | 108 | 0.440 |
Why?
| Cerebellopontine Angle | 2 | 2008 | 6 | 0.430 |
Why?
| Cerebellar Neoplasms | 2 | 2008 | 22 | 0.430 |
Why?
| Recurrence | 7 | 2017 | 652 | 0.420 |
Why?
| Postoperative Period | 3 | 2019 | 170 | 0.420 |
Why?
| Middle Ear Ventilation | 3 | 2002 | 14 | 0.420 |
Why?
| Endolymphatic Sac | 4 | 2002 | 7 | 0.410 |
Why?
| Audiometry, Evoked Response | 5 | 2006 | 7 | 0.400 |
Why?
| Antiemetics | 3 | 2012 | 32 | 0.390 |
Why?
| Patient Selection | 1 | 2012 | 253 | 0.380 |
Why?
| Prosthesis Implantation | 2 | 2008 | 44 | 0.370 |
Why?
| Infant | 6 | 2018 | 3567 | 0.370 |
Why?
| Evoked Potentials, Auditory | 4 | 2006 | 101 | 0.360 |
Why?
| Tomography, X-Ray Computed | 9 | 2013 | 1159 | 0.360 |
Why?
| Chronic Disease | 6 | 2016 | 567 | 0.350 |
Why?
| Proteus mirabilis | 1 | 2009 | 2 | 0.340 |
Why?
| Proteus Infections | 1 | 2009 | 4 | 0.340 |
Why?
| Bacteroidaceae Infections | 1 | 2009 | 4 | 0.340 |
Why?
| Bacteroides | 1 | 2009 | 14 | 0.340 |
Why?
| Brain Abscess | 1 | 2009 | 12 | 0.340 |
Why?
| Cerebellar Diseases | 1 | 2009 | 17 | 0.330 |
Why?
| Fistula | 3 | 2000 | 24 | 0.330 |
Why?
| Time Factors | 10 | 2013 | 2903 | 0.320 |
Why?
| Blood Glucose | 1 | 2011 | 439 | 0.310 |
Why?
| Electric Impedance | 2 | 2018 | 41 | 0.310 |
Why?
| Succinate Dehydrogenase | 1 | 2008 | 23 | 0.310 |
Why?
| Paraganglioma | 1 | 2008 | 14 | 0.310 |
Why?
| Prosthesis Design | 3 | 2014 | 237 | 0.300 |
Why?
| Neoplasms, Multiple Primary | 1 | 2008 | 43 | 0.300 |
Why?
| Vestibule, Labyrinth | 2 | 2004 | 16 | 0.300 |
Why?
| Facial Nerve | 3 | 2023 | 20 | 0.300 |
Why?
| DNA Mutational Analysis | 1 | 2008 | 175 | 0.290 |
Why?
| Prognosis | 6 | 2019 | 1942 | 0.290 |
Why?
| Bone Matrix | 2 | 2004 | 18 | 0.280 |
Why?
| Risk Factors | 6 | 2017 | 3613 | 0.280 |
Why?
| Databases, Factual | 3 | 2024 | 658 | 0.280 |
Why?
| Arkansas | 4 | 2017 | 1977 | 0.280 |
Why?
| Drainage | 3 | 2008 | 78 | 0.280 |
Why?
| Attention | 3 | 2017 | 175 | 0.270 |
Why?
| United States | 5 | 2024 | 4860 | 0.260 |
Why?
| Equipment Design | 5 | 2010 | 284 | 0.260 |
Why?
| Cholesteatoma | 2 | 2012 | 6 | 0.260 |
Why?
| Noise | 3 | 2008 | 39 | 0.260 |
Why?
| Posture | 2 | 2008 | 59 | 0.250 |
Why?
| Histamine H1 Antagonists | 1 | 2004 | 10 | 0.250 |
Why?
| GABA Modulators | 1 | 2004 | 9 | 0.250 |
Why?
| Muscarinic Antagonists | 1 | 2004 | 21 | 0.240 |
Why?
| Genetic Predisposition to Disease | 1 | 2008 | 510 | 0.240 |
Why?
| Up-Regulation | 2 | 2005 | 452 | 0.240 |
Why?
| Auditory Brain Stem Implants | 1 | 2024 | 3 | 0.240 |
Why?
| Memory Disorders | 1 | 2004 | 54 | 0.240 |
Why?
| Transplants | 1 | 2004 | 19 | 0.240 |
Why?
| Hearing Disorders | 3 | 1999 | 11 | 0.240 |
Why?
| Evoked Potentials, Auditory, Brain Stem | 6 | 2001 | 27 | 0.230 |
Why?
| Memory, Short-Term | 1 | 2004 | 73 | 0.230 |
Why?
| Bell Palsy | 1 | 2023 | 6 | 0.230 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 173 | 0.230 |
Why?
| Facial Paralysis | 1 | 2023 | 24 | 0.230 |
Why?
| Prostheses and Implants | 2 | 2002 | 54 | 0.220 |
Why?
| Cross-Over Studies | 4 | 2017 | 224 | 0.220 |
Why?
| Myringoplasty | 2 | 2013 | 4 | 0.220 |
Why?
| Decision Making | 2 | 2017 | 265 | 0.220 |
Why?
| Cognition Disorders | 1 | 2004 | 218 | 0.210 |
Why?
| Ceramics | 1 | 2002 | 7 | 0.210 |
Why?
| Foreign Bodies | 1 | 2023 | 65 | 0.210 |
Why?
| Endoscopy | 3 | 2023 | 124 | 0.210 |
Why?
| Titanium | 1 | 2002 | 48 | 0.210 |
Why?
| Guanylate Cyclase | 1 | 2002 | 9 | 0.210 |
Why?
| Cicatrix | 1 | 2002 | 40 | 0.210 |
Why?
| Reaction Time | 8 | 2006 | 216 | 0.210 |
Why?
| Nasopharyngeal Neoplasms | 1 | 2002 | 6 | 0.200 |
Why?
| Ear, External | 1 | 2002 | 10 | 0.200 |
Why?
| Bone Regeneration | 1 | 2002 | 68 | 0.200 |
Why?
| Skull Neoplasms | 1 | 2002 | 5 | 0.200 |
Why?
| Ear Neoplasms | 1 | 2002 | 11 | 0.200 |
Why?
| Action Potentials | 3 | 2017 | 132 | 0.200 |
Why?
| Speech Perception | 1 | 2022 | 89 | 0.190 |
Why?
| Incus | 2 | 2012 | 4 | 0.190 |
Why?
| Diagnosis, Differential | 3 | 2016 | 1037 | 0.190 |
Why?
| Electroencephalography | 2 | 2002 | 306 | 0.190 |
Why?
| Velopharyngeal Insufficiency | 1 | 2021 | 19 | 0.190 |
Why?
| Risk Assessment | 3 | 2013 | 1259 | 0.180 |
Why?
| Barotrauma | 1 | 2000 | 1 | 0.180 |
Why?
| Sleep | 1 | 2002 | 184 | 0.180 |
Why?
| Hospitals, University | 1 | 2000 | 77 | 0.180 |
Why?
| Antibodies | 2 | 2015 | 154 | 0.180 |
Why?
| Patient Admission | 1 | 2000 | 77 | 0.180 |
Why?
| Ambulatory Surgical Procedures | 1 | 2000 | 46 | 0.180 |
Why?
| Gelatin Sponge, Absorbable | 1 | 1999 | 5 | 0.180 |
Why?
| Disease Models, Animal | 3 | 2001 | 1455 | 0.170 |
Why?
| Hemostatics | 1 | 1999 | 16 | 0.170 |
Why?
| Psychomotor Performance | 3 | 2017 | 130 | 0.170 |
Why?
| Mastoiditis | 1 | 1999 | 7 | 0.170 |
Why?
| Severity of Illness Index | 4 | 2006 | 945 | 0.160 |
Why?
| Pain Measurement | 2 | 2011 | 240 | 0.160 |
Why?
| Gerbillinae | 3 | 2003 | 9 | 0.160 |
Why?
| Pilot Projects | 4 | 2017 | 699 | 0.150 |
Why?
| Evoked Potentials | 1 | 2018 | 72 | 0.150 |
Why?
| Operative Time | 1 | 2018 | 73 | 0.150 |
Why?
| Hospital Costs | 1 | 2018 | 71 | 0.150 |
Why?
| Hearing Tests | 2 | 2014 | 23 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 595 | 0.150 |
Why?
| Electrophysiological Phenomena | 1 | 2017 | 18 | 0.150 |
Why?
| Meclizine | 3 | 2012 | 5 | 0.150 |
Why?
| Lorazepam | 3 | 2012 | 11 | 0.150 |
Why?
| Fluorodeoxyglucose F18 | 2 | 2011 | 192 | 0.150 |
Why?
| Promethazine | 3 | 2012 | 12 | 0.150 |
Why?
| Evidence-Based Medicine | 2 | 2016 | 247 | 0.150 |
Why?
| Algorithms | 3 | 2020 | 615 | 0.150 |
Why?
| Cross-Sectional Studies | 2 | 2023 | 1557 | 0.140 |
Why?
| Immune System Diseases | 1 | 1997 | 8 | 0.140 |
Why?
| Perception | 1 | 2017 | 116 | 0.140 |
Why?
| Thalamus | 2 | 2006 | 36 | 0.130 |
Why?
| Granulation Tissue | 2 | 2009 | 10 | 0.130 |
Why?
| Animals | 9 | 2023 | 13187 | 0.130 |
Why?
| Clinical Trials as Topic | 2 | 2012 | 461 | 0.130 |
Why?
| Fibroma, Ossifying | 1 | 1995 | 2 | 0.130 |
Why?
| Fibrous Dysplasia of Bone | 1 | 1995 | 6 | 0.130 |
Why?
| Cochlear Diseases | 1 | 1995 | 4 | 0.130 |
Why?
| Nanocapsules | 1 | 2015 | 7 | 0.130 |
Why?
| Paranasal Sinus Neoplasms | 1 | 1995 | 21 | 0.120 |
Why?
| Rotation | 3 | 2004 | 45 | 0.120 |
Why?
| Cochlea | 1 | 1995 | 19 | 0.120 |
Why?
| Indocyanine Green | 1 | 2015 | 34 | 0.120 |
Why?
| Acoustic Stimulation | 1 | 1995 | 97 | 0.120 |
Why?
| Photochemotherapy | 1 | 2015 | 34 | 0.120 |
Why?
| Magnetic Resonance Imaging | 4 | 2017 | 1537 | 0.120 |
Why?
| Rats, Inbred Lew | 2 | 2005 | 69 | 0.120 |
Why?
| Second-Look Surgery | 1 | 2013 | 3 | 0.120 |
Why?
| Antigen-Antibody Complex | 1 | 1993 | 35 | 0.110 |
Why?
| Biofeedback, Psychology | 1 | 2013 | 17 | 0.110 |
Why?
| Age Factors | 2 | 2010 | 1087 | 0.110 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2016 | 549 | 0.110 |
Why?
| Research Design | 2 | 2013 | 344 | 0.110 |
Why?
| Electric Stimulation | 1 | 2013 | 118 | 0.110 |
Why?
| Dilatation | 2 | 2023 | 26 | 0.110 |
Why?
| Vestibular Diseases | 1 | 1993 | 8 | 0.110 |
Why?
| Wound Healing | 3 | 2003 | 204 | 0.110 |
Why?
| Bone Demineralization Technique | 2 | 2004 | 3 | 0.110 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2013 | 123 | 0.110 |
Why?
| Catheterization | 2 | 2023 | 96 | 0.110 |
Why?
| Saccule and Utricle | 1 | 2012 | 2 | 0.100 |
Why?
| Functional Laterality | 2 | 2012 | 88 | 0.100 |
Why?
| Reflex, Vestibulo-Ocular | 1 | 2012 | 6 | 0.100 |
Why?
| Prospective Studies | 1 | 2018 | 2364 | 0.100 |
Why?
| Postoperative Care | 2 | 2003 | 102 | 0.100 |
Why?
| Dose-Response Relationship, Drug | 2 | 2005 | 1376 | 0.100 |
Why?
| Round Window, Ear | 2 | 2005 | 6 | 0.100 |
Why?
| Homeostasis | 2 | 2002 | 200 | 0.100 |
Why?
| Fibrosis | 3 | 2012 | 179 | 0.090 |
Why?
| Cognition | 1 | 2013 | 338 | 0.090 |
Why?
| Rats | 4 | 2005 | 3305 | 0.090 |
Why?
| Suture Anchors | 1 | 2010 | 11 | 0.090 |
Why?
| Prefrontal Cortex | 3 | 2017 | 82 | 0.090 |
Why?
| Case-Control Studies | 2 | 2006 | 1131 | 0.090 |
Why?
| Infusions, Intravenous | 2 | 2009 | 206 | 0.090 |
Why?
| Logistic Models | 1 | 2012 | 888 | 0.090 |
Why?
| Vestibular Function Tests | 2 | 2012 | 8 | 0.090 |
Why?
| Double-Blind Method | 2 | 2017 | 681 | 0.080 |
Why?
| Databases as Topic | 2 | 2000 | 37 | 0.080 |
Why?
| Speech Intelligibility | 1 | 2008 | 15 | 0.080 |
Why?
| Television | 1 | 2008 | 16 | 0.080 |
Why?
| Equipment Safety | 1 | 2008 | 12 | 0.080 |
Why?
| Dominance, Cerebral | 1 | 2008 | 27 | 0.080 |
Why?
| Transcutaneous Electric Nerve Stimulation | 1 | 2008 | 10 | 0.080 |
Why?
| Otitis Media | 1 | 2008 | 29 | 0.080 |
Why?
| Retreatment | 1 | 2008 | 57 | 0.080 |
Why?
| Consensus | 2 | 2020 | 148 | 0.080 |
Why?
| Proline | 1 | 2008 | 30 | 0.080 |
Why?
| Secondary Prevention | 1 | 2008 | 78 | 0.080 |
Why?
| Reading | 1 | 2008 | 83 | 0.080 |
Why?
| Eating | 1 | 2008 | 162 | 0.080 |
Why?
| Codon | 1 | 2008 | 47 | 0.080 |
Why?
| Amino Acid Substitution | 1 | 2008 | 82 | 0.080 |
Why?
| Activities of Daily Living | 1 | 2008 | 174 | 0.070 |
Why?
| Appendicitis | 1 | 1988 | 59 | 0.070 |
Why?
| Leucine | 1 | 2008 | 116 | 0.070 |
Why?
| Brain Stem | 2 | 2006 | 57 | 0.070 |
Why?
| Alleles | 1 | 2008 | 250 | 0.070 |
Why?
| Chromosome Deletion | 1 | 2008 | 140 | 0.070 |
Why?
| Auditory Cortex | 1 | 2006 | 22 | 0.070 |
Why?
| Autoantibodies | 2 | 1997 | 116 | 0.070 |
Why?
| Feasibility Studies | 1 | 2008 | 375 | 0.070 |
Why?
| Therapy, Computer-Assisted | 1 | 2006 | 30 | 0.070 |
Why?
| Base Sequence | 1 | 2008 | 643 | 0.070 |
Why?
| Radiography | 1 | 2008 | 489 | 0.070 |
Why?
| Genotype | 1 | 2008 | 537 | 0.070 |
Why?
| Radiosurgery | 1 | 2008 | 118 | 0.070 |
Why?
| Energy Metabolism | 1 | 2008 | 282 | 0.070 |
Why?
| Task Performance and Analysis | 1 | 2006 | 52 | 0.070 |
Why?
| Silicones | 1 | 2005 | 9 | 0.070 |
Why?
| Dermatitis, Allergic Contact | 1 | 2005 | 12 | 0.070 |
Why?
| Connective Tissue | 2 | 1997 | 22 | 0.070 |
Why?
| Cohort Studies | 2 | 2013 | 1422 | 0.060 |
Why?
| Electrophoresis, Agar Gel | 1 | 2005 | 11 | 0.060 |
Why?
| Buffers | 1 | 2005 | 9 | 0.060 |
Why?
| Radiopharmaceuticals | 1 | 2006 | 209 | 0.060 |
Why?
| Cerebrospinal Fluid Otorrhea | 2 | 1995 | 3 | 0.060 |
Why?
| Injections | 1 | 2005 | 55 | 0.060 |
Why?
| Phosphates | 1 | 2005 | 47 | 0.060 |
Why?
| Prednisolone | 2 | 1995 | 55 | 0.060 |
Why?
| Sodium Chloride | 1 | 2005 | 57 | 0.060 |
Why?
| Protein Isoforms | 1 | 2005 | 119 | 0.060 |
Why?
| Drug Combinations | 1 | 2005 | 123 | 0.060 |
Why?
| Emergency Service, Hospital | 1 | 2009 | 486 | 0.060 |
Why?
| Auditory Brain Stem Implantation | 1 | 2024 | 3 | 0.060 |
Why?
| Pregnancy Complications | 1 | 1988 | 382 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2009 | 744 | 0.060 |
Why?
| Single-Blind Method | 2 | 2013 | 116 | 0.050 |
Why?
| Densitometry | 1 | 2002 | 11 | 0.050 |
Why?
| Neuropsychological Tests | 1 | 2004 | 353 | 0.050 |
Why?
| Electrophoresis | 1 | 2002 | 16 | 0.050 |
Why?
| Sound Spectrography | 1 | 2002 | 10 | 0.050 |
Why?
| Glycerol | 1 | 2002 | 15 | 0.050 |
Why?
| Bone Substitutes | 1 | 2002 | 11 | 0.050 |
Why?
| Matched-Pair Analysis | 1 | 2002 | 11 | 0.050 |
Why?
| Motion Sickness | 1 | 2002 | 8 | 0.050 |
Why?
| Reticular Formation | 1 | 2002 | 28 | 0.050 |
Why?
| Swine | 1 | 2023 | 393 | 0.050 |
Why?
| Laser Therapy | 1 | 2002 | 84 | 0.050 |
Why?
| RNA | 1 | 2002 | 170 | 0.050 |
Why?
| Nausea | 1 | 2002 | 50 | 0.050 |
Why?
| RNA, Messenger | 1 | 2005 | 1105 | 0.050 |
Why?
| Graft Survival | 1 | 2002 | 150 | 0.050 |
Why?
| Immunohistochemistry | 2 | 2002 | 973 | 0.050 |
Why?
| Cerumen | 1 | 2001 | 1 | 0.050 |
Why?
| Pharynx | 1 | 2021 | 33 | 0.050 |
Why?
| Cochlear Aqueduct | 1 | 2000 | 1 | 0.050 |
Why?
| Perilymph | 2 | 2002 | 3 | 0.050 |
Why?
| Anesthetics | 1 | 2000 | 36 | 0.040 |
Why?
| Analysis of Variance | 1 | 2001 | 562 | 0.040 |
Why?
| Preoperative Care | 1 | 2000 | 164 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2002 | 740 | 0.040 |
Why?
| Skull Base | 1 | 1999 | 31 | 0.040 |
Why?
| Endolymphatic Hydrops | 1 | 1998 | 3 | 0.040 |
Why?
| International Agencies | 1 | 2018 | 13 | 0.040 |
Why?
| Bone and Bones | 1 | 2002 | 469 | 0.040 |
Why?
| Brain | 1 | 2007 | 1328 | 0.040 |
Why?
| Surface Tension | 1 | 1998 | 1 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2002 | 1193 | 0.040 |
Why?
| Speech Discrimination Tests | 2 | 1994 | 5 | 0.040 |
Why?
| Acoustics | 1 | 1998 | 33 | 0.040 |
Why?
| Internationality | 1 | 2018 | 36 | 0.040 |
Why?
| Neurosurgical Procedures | 1 | 1999 | 121 | 0.040 |
Why?
| Parietal Lobe | 1 | 2017 | 26 | 0.040 |
Why?
| Immunoglobulins | 1 | 1997 | 79 | 0.040 |
Why?
| Societies, Medical | 1 | 2018 | 175 | 0.040 |
Why?
| Disease Progression | 1 | 2000 | 825 | 0.040 |
Why?
| Food Hypersensitivity | 1 | 1997 | 100 | 0.030 |
Why?
| Autoimmune Diseases | 1 | 1997 | 101 | 0.030 |
Why?
| Premedication | 1 | 1995 | 21 | 0.030 |
Why?
| Brain Neoplasms | 1 | 1999 | 287 | 0.030 |
Why?
| Nystagmus, Pathologic | 1 | 1995 | 4 | 0.030 |
Why?
| Bone Cysts, Aneurysmal | 1 | 1995 | 4 | 0.030 |
Why?
| Ethmoid Sinus | 1 | 1995 | 12 | 0.030 |
Why?
| Electronystagmography | 1 | 1995 | 1 | 0.030 |
Why?
| Speech Reception Threshold Test | 1 | 1995 | 1 | 0.030 |
Why?
| Fibrin Tissue Adhesive | 1 | 1995 | 12 | 0.030 |
Why?
| Frontal Sinus | 1 | 1995 | 9 | 0.030 |
Why?
| Cochlear Microphonic Potentials | 1 | 1995 | 1 | 0.030 |
Why?
| Organ of Corti | 1 | 1995 | 1 | 0.030 |
Why?
| Myelography | 1 | 1995 | 2 | 0.030 |
Why?
| Guinea Pigs | 1 | 1995 | 74 | 0.030 |
Why?
| Bone Transplantation | 1 | 1995 | 47 | 0.030 |
Why?
| Practice Guidelines as Topic | 1 | 2018 | 449 | 0.030 |
Why?
| Hearing Loss, Central | 1 | 1994 | 4 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 1995 | 194 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2017 | 903 | 0.030 |
Why?
| Keratinocytes | 1 | 2015 | 90 | 0.030 |
Why?
| Sex Factors | 2 | 1995 | 691 | 0.030 |
Why?
| Anti-Inflammatory Agents | 1 | 1995 | 161 | 0.030 |
Why?
| Electrooculography | 1 | 1993 | 13 | 0.030 |
Why?
| Control Groups | 1 | 2013 | 9 | 0.030 |
Why?
| Linear Models | 1 | 1994 | 280 | 0.030 |
Why?
| Reference Values | 1 | 1994 | 310 | 0.030 |
Why?
| Epithelium | 1 | 1993 | 65 | 0.030 |
Why?
| Immunoenzyme Techniques | 1 | 1993 | 143 | 0.030 |
Why?
| Fascia | 1 | 2013 | 6 | 0.030 |
Why?
| Gambling | 1 | 2013 | 18 | 0.030 |
Why?
| Blood Vessels | 1 | 1993 | 72 | 0.030 |
Why?
| Immunoglobulin G | 1 | 1993 | 186 | 0.030 |
Why?
| Data Interpretation, Statistical | 1 | 2013 | 158 | 0.030 |
Why?
| Impulsive Behavior | 1 | 2013 | 77 | 0.030 |
Why?
| Reward | 1 | 2013 | 110 | 0.030 |
Why?
| Sensitivity and Specificity | 1 | 1994 | 861 | 0.030 |
Why?
| Collagen | 1 | 1993 | 206 | 0.030 |
Why?
| Choice Behavior | 1 | 2013 | 85 | 0.030 |
Why?
| Cadaver | 1 | 2012 | 97 | 0.030 |
Why?
| Rats, Sprague-Dawley | 2 | 2002 | 1597 | 0.020 |
Why?
| Device Removal | 1 | 2005 | 85 | 0.020 |
Why?
| Oval Window, Ear | 1 | 2002 | 2 | 0.010 |
Why?
| Models, Anatomic | 1 | 2002 | 39 | 0.010 |
Why?
| Habituation, Psychophysiologic | 1 | 2002 | 33 | 0.010 |
Why?
| Electromyography | 1 | 2002 | 131 | 0.010 |
Why?
| Pregnancy | 1 | 1988 | 2607 | 0.010 |
Why?
| Osteogenesis | 1 | 2001 | 352 | 0.010 |
Why?
| Osteocytes | 1 | 2001 | 207 | 0.010 |
Why?
| Survival Rate | 1 | 1999 | 894 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1997 | 162 | 0.010 |
Why?
| Headache | 1 | 1995 | 76 | 0.010 |
Why?
| Craniotomy | 1 | 1994 | 25 | 0.010 |
Why?
|
|
Dornhoffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Same Department
People who are also in this person's primary department.
|